Ion transport across a phospholipid membrane mediated by the peptide trichogin GA IV  by Kropacheva, T.N & Raap, J
Ion transport across a phospholipid membrane mediated by the
peptide trichogin GA IV
T.N. Kropachevaa, J. Raapb,*
aDepartment of Chemistry, Udmurt State University, Izhevsk, Russia
bLeiden Institute of Chemistry, Gorlaeus Laboratories, Leiden University, P.O. Box 9502, 2300 RA Leiden, The Netherlands
Received 26 April 2002; received in revised form 22 July 2002; accepted 26 September 2002
Abstract
Trichogin GA IV is a special member of a class of peptaibols that are linear peptide antibiotics of fungal origin, characterised by the
presence of a variable number of a-aminoisobutyric acid residues, an acyl group at the N-terminus and a 1,2-amino alcohol at the C-terminus.
Most of the peptaibols display ion-channel-forming or at least membrane-modifying properties. The 11-residue-long trichogin GA IV is not
only one of shortest peptaibols, but it is also unique for its n-octanoyl group instead of the more common found acetyl group at the N-
terminus. For the first time we have found that this lipopeptaibol is able to enhance conduction of monovalent cations through membranes of
large unilamellar vesicles (LUVs). The influence of the [Leu-OMe]trichogin GA IV analogue (TRI) on ion permeation was studied under a
variety of conditions (lipid composition, lipid-to-peptide ratio and a transmembrane potential). Parallel experiments were performed with the
16-residue long, channel-forming peptaibol, zervamicin (ZER). For the two peptides, the permeability between K+ and Na+ was found to be
different. In addition, the ion diffusion rate dependencies on the peptide concentration are observed to be different. This might indicate that a
different number of aggregated molecules are involved in the rate-limiting step, i.e. 3–4 (TRI) and 4–7 (ZER). In the presence of TRI,
dissipation of the transmembrane potential, Dw, was observed with a rate to be dependent on the magnitude of both initial Dw and peptide
concentration. Both peptides were activated by a cis-positive but not by cis-negative Dw. Under identical conditions the ion-conducting
efficiency of zervamicin was 100–200 times higher than that of trichogin. Our results show that, unlike for zervamicin, the membrane-
modifying activity of trichogin is not associated with a channel mechanism.
D 2002 Elsevier Science B.V. All rights reserved.
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1. Introduction
Peptaibols, such as alamethicin, suzukacilin, trichorzia-
nin, zervamicin, antiamoebin, trichogin, etc., are linear
peptides of fungal origin, characterised by a high content
of helix-promoting a-aminoisobutyric acid residues, an
acylated N-terminus and a 1,2-amino alcohol at the C-
terminus (Table 1). Many peptaibol antibiotics display ion
channel forming properties and can serve as good model
systems for a better understanding of the function of
complex channel proteins. One of the longest and best
studied peptaibols is the 20-residue-long alamethicin (re-
viewed in Refs. [1–6]). Natural alamethicin (a mixture of
several close related analogues) forms voltage-gated ion
channels in a variety of lipid membranes with discrete
conductance multilevels. It is generally accepted that the
channels are formed by aggregation of a variable number of
amphipathic helices into transmembrane bundles.
Zervamicins belong to another family of peptaibols, i.e.
16-residue antibiotic peptides isolated from Emericellopsis
salmosynnemata [7]. Themajor component of the zervamicin
analogues, zervamicin IIB (Table 1), shows almost the same
ion conducting properties as alamethicin [8,9]. The voltage-
induced conductance is asymmetric with a higher current
observed at cis-positive potentials compared to that at a cis-
negative voltage [4,5,9,10]. The zervamicin structure in the
crystal state and solution is also typical for that of peptaibols
[11–13]. The amphipathic helical structure has a well-pro-
nounced polar face, which can line the interior of the channel.
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The total length of the zervamicin helix is about 26–29 A˚,
which is enough to span the hydrophobic core of the bilayer
(f 30 A˚). Thus, similar to alamethicin, the membrane
activity of zervamicin is likely associated with the formation
of voltage-gated channels via a barrel-stave mechanism.
One of the shortest peptaibol antibiotics is the 11-
residue-long trichogin GA IV (Table 1) isolated from the
cultures of Trichoderma longibrachiatum [14]. This so-
called lipopeptaibol is characterised by a lipophilic group
attached to the N-terminus [15]. Similar to the longer
peptaibols, trichogin GA IV exhibits a helical structure with
the hydrophilic face comprised of only four glycine resi-
dues. In spite of its shorter length (f 16 A˚), trichogin
shows considerable membrane-modifying activity [14–17].
However, the long axis of the trichogin helix was oriented
parallel to the membrane surface [17] and it was concluded
that the most likely mode of trichogin action (at least in the
absence of a transmembrane potential) is according to a
‘‘carpet-like’’ mechanism [18,19].
The present paper aimed at the study of the membrane
activity of the synthetic [Leu11OMe]trichogin GA IV ana-
logue (Table 1), which was shown to have a conformation
and activity comparable to that of natural trichogin GA IV
[14,16]. Since the trichogin-induced membrane permeation
was previously characterised only via carboxyfluorescein
leakage, it was of interest to see whether trichogin can also
induce permeation of small inorganic ions through a mem-
brane. The transmembrane fluxes of sodium and potassium
cations in the presence of trichogin were studied in order to
see if there is some discrimination in their transport mech-
anism often observed in membrane systems [3,20]. The
experiments were performed with large unilamellar vesicles
(LUVs) prepared from zwitterionic (egg L-a-phosphatidyl-
choline (PC)) and acidic (egg L-a-phosphatidyl-DL-glycerol
(PG)) lipids. Since many peptaibols exhibit potential-
dependent behaviour, the influence of the transmembrane
potential on the activity of trichogin was also studied. All
experiments were performed in comparison with the chan-
nel-forming zervamicin to get additional information about
the mechanism of trichogin-induced ion conduction.
2. Materials and methods
LUVs were prepared by rapid extrusion of an aqueous
egg PC or egg PG (Sigma). A high-pressure extruder with a
stack of two membrane polycarbonate filters (Nucleopore,
100-nm pore size) was used as described in Ref. [21]. To
determine the internal volume, vesicles were prepared in
200 mM KCl and the external solution was exchanged for
200 mM NaCl by passage of the vesicles through a
Sephadex G-50 column. The entrapped K+ was released
by addition of the pore-forming peptide gramicidin D
(GRA, Molecular Probes) and its concentration was deter-
mined with a K+-selective electrode (Orion). The trapped
volume per mole of PC was found to be 1.2 l, which is close
to reported values for PC LUVs produced by extrusion
through 100 nm filters [21]. The distribution of vesicle sizes
was determined by photon correlation spectroscopy using a
Zetasizer 3000 (Malvern Instruments). The Z-average size
was found to be 90 nm.
The PC concentration was determined by an enzymatic
colorimetric method using a commercial kit (PL MRP2;
Boehringer Mannheim). The PG content was measured by
inorganic phosphate analysis according to Ref. [22].
Zervamicin (ZER, a 1:1 mixture of the closely related
analogues zervamicins IIA and IIB) was isolated from the
biomass obtained from a culture of E. salmosynnemata
according to Ref. [23]. [Leu11OMe]trichogin GA IV
(TRI), a kind gift of Prof. C. Toniolo, was synthesised as
described in Ref. [16]. Small aliquots of a stock solution of
peptide in dimethyl sulfoxide (DMSO) were added to the
vesicles up to a final concentration of less than 2% DMSO
(by volume).
For the imposition of a transmembrane potential, Dw,
outside positive vesicles were prepared in solution contain-
ing 200 mM KCl and 10 mM TrisHCl (pH 7.4). For
generation of Dw, outside negative vesicles were prepared
in 2 mM KCl, 198 mM NaCl and 10 mM TrisHCl (pH 7.4).
To produce K+ transmembrane gradients, the stock solution
was diluted 100-fold into one containing variable concen-
trations of KCl and NaCl (total concentration 200 mM) and
10 mM TrisHCl (pH 7.4). Generation of Dw by addition of
valinomycin (VAL, Sigma) to vesicles was followed with
the potential-sensitive probes safranine T (SAF, Riedel-de-
Haen) and oxonol VI (OXO, Molecular Probes).
For K+- or Na+-uptake studies, vesicles were prepared in
200 mM Me4NCl, 10 mM TrisHCl (pH 7.4) in the presence
of the f 50 AM potassium benzofuran isophtalate (PBFI,
Molecular Probes). The unbound indicator was removed by
passage through a Sephadex G-50 column pre-equilibrated
with the same buffer (except for the indicator). The solution
Table 1
Amino acid sequence of selected peptaibols
Alamethicin (Rf = 30) Ac-Aib
1-Pro2-Aib3-Ala4-Aib5-Ala6(Aib6)-Gln7-Aib8-Val9-Aib10-Gly11-Leu12-Aib13-Pro14-Val15-Aib16-Aib17-Glu18-Gln19-Phl20
Alamethicin (Rf = 50) Ac-Aib
1-Pro2-Aib3-Ala4-Aib5-Ala6(Aib6)-Gln7-Aib8-Val9-Aib10-Gly11-Leu12-Aib13-Pro14-Val15-Aib16-Aib17-Gln18-Gln19-Phl20
Zervamicin IIA Ac-Trp1-Ile2-Gln3-Aib4-Ile5-Thr6-Aib7-Leu8-Aib9-Hyp10-Gln11-Aib12-Hyp13-Aib14-Pro15-Phl16
Zervamicin IIB Ac-Trp1-Ile2-Gln3-Iva4-Ile5-Thr6-Aib7-Leu8-Aib9-Hyp10-Gln11-Aib12-Hyp13-Aib14-Pro15-Phl16
Leu-Zervamicin Ac-Leu1-Ile2-Gln3-Iva4-Ile5-Thr6-Aib7-Leu8-Aib9-Hyp10-Gln11-Aib12-Hyp13-Aib14-Pro15-Phl16
Trichogin GA IV n-Oct-Aib1-Gly2-Leu3-Aib4-Gly5-Gly6-Leu7-Aib8-Gly9-Ile10-Lol11
[LeuOMe] Trichogin GA IV n-Oct-Aib1-Gly2-Leu3-Aib4-Gly5-Gly6-Leu7-Aib8-Gly9-Ile10-Leu-OMe11
n-Oct = n-octanoyl; Phl = L-phenylalaninol; Lol = L-leucinol; Aib =a-aminoisobutyric acid.
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was diluted 50–100 times into the medium containing
different amounts of KCl (NaCl), Me4NCl (total concen-
tration 200 mM) and 10 mM TrisHCl (pH 7.4).
Fluorescence was measured with a Perkin-Elmer lumi-
nescence spectrofluorimeter LS50 B. The absorption spectra
were obtained with a Perkin-Elmer Lambda 900 UV/VIS/
NIR spectrophotometer. All experiments were performed at
room temperature (20F 1 jC).
3. Results
3.1. Binding of peptide to PC vesicles
To study the peptide-to-lipid binding, the intrinsic fluo-
rescence of ZER (due to the presence of the Trp1 residue)
was examined under different conditions. In aqueous sol-
ution the maximum of the ZER emission spectrum is at 360
nm. Upon addition of PC vesicles (L:P < 1) the intensity of
fluorescence decreases without changing the emission band
position (Fig. 1). Further addition of lipid results into a
gradual shift of the emission band to 340 nm. The titration
curve (Fig. 1, inset) shows a fast saturation at L:Pf 5. This
result indicates that, under the conditions used in our
experiments described below (L:P>1000) ZER molecules
bind quantitatively to the membrane.
The affinity of TRI for phospholipid vesicles cannot be
determined in the way described above. However, due to the
lipophilic nature of TRI, its binding to vesicles is expected
to be even stronger.
The blue shift of ZER fluorescence (362! 341 nm)
upon binding to vesicles (Fig. 1A) indicates an increase in
hydrophobicity of the environment at the N-terminus of the
peptide. For comparison, the position of the maximum of
fluorescence was measured in a number of solvents of
decreased polarity, i.e. kmax = 362 nm (water, e= 79), 356
nm (DMSO, e = 47), 343 nm (methanol, e = 33), 340 nm
(CH2Cl2, e = 9) and 340 nm (n-hexane, e = 2). Thus, the
fluorescence maximum at 341 nm for vesicle-bound ZER
may correspond to penetration of the N-terminal Trp1-
residue into the hydrophobic core of the membrane
(e = 2–4).
3.2. Peptide-mediated K+- and Na+-influx
In order to monitor the peptaibol-mediated potassium (or
sodium) influx, the encapsulated fluorescent indicator PBFI
was employed. Preliminarily, the spectral response of PBFI
to intravesicular K+ was determined by a standard procedure
[24]. To PC (or PG) LUVs, loaded with the indicator,
increasing amounts of KCl were added in the presence of
the pore-forming antibiotic GRA (Fig. 2). The increase of
fluorescence was analysed to determine the dissociation
constant (Kd) of the indicator–cation complex (Fig. 2,
inset). Under our experimental conditions, the Kd values
of PBFI determined for K+ are 7.8 mM (PC LUVs) and 7.6
mM (PG LUVs).
Although PBFI was primary designed as a fluorescent
indicator for K+, it can also be used to monitor the Na+
concentrations (see inset in Fig. 2) [25]. The dissociation
constants of the PBFI–Na+ complex for different types of
phospholipids are 23.4 mM (PC LUVs) and 15.4 mM (PG
LUVs). The concentration range over which the maximum
sensitivity of the indicator corresponds to approximately 1–
40 mM of K+ (Na+).
The peptide-mediated K+ uptake into vesicles was
studied by measuring the fluorescence of encapsulated PBFI
as a function of time upon addition of appropriate amounts
Fig. 1. Fluorescence emission spectrum of ZER (CZER = 0.66 AM) in
aqueous solution containing 200 mM KCl and 10 mM TrisHCl (pH 7.4)
(curve 1) and in the presence of variable amounts of PC vesicles (loaded
with the same buffer), i.e. CPC = 0.06 AM (curve 2); 0.28 AM (3); 0.56 AM
(4); 1.11 AM (5); 2.22 AM (6). kex = 280 nm. Inset: fluorescence intensity at
kmax = 340 nm upon titration with PC vesicles.
Fig. 2. Calibration of the PBFI fluorescence emission. To PC vesicles,
loaded with f 50 AM PBFI in 200 mM (CH3)4NCl, 10 mM TrisHCl (pH
7.4) with the same external medium (except of PBFI), small aliquots of
KCl were added to indicated final concentrations in the presence of GRA
(3 AM). CPC = 213 AM; kex = 340 nm, kem = 525 nm; 430 nm cut-off filter.
Inset: PBFI fluorescence emission as a function of K+ and Na+
concentrations.
T.N. Kropacheva, J. Raap / Biochimica et Biophysica Acta 1567 (2002) 193–203 195
of peptide in the presence of a K+-transmembrane gradient
(Fig. 3A). No increase of PBFI fluorescence is observed in
the absence of peptide, which indicates that the PC mem-
brane is highly impermeable to K+ ions. Upon addition of
TRI, an initial steep increase of PBFI fluorescence is
observed due to the rapid influx of K+ ions from the
extravesicular space. A further leakage of K+ ions is sped
down since it becomes tightly coupled to a counterflow of
Me4N
+ ions, so that the slower phase of the fluorescence
curves depends on the rate of TRI-mediated K+/Me4N
+
exchange transport. At the end of each experiment GRA
was added to achieve complete equilibration of K+ concen-
tration across the membrane. The concentration of cations
inside the vesicles Cin (Fig. 3B) was calculated from the
preliminarily determined values of Kd:
Cin ¼ KdðI  I0Þ=ðImax  IÞ
where I is the fluorescence at a given time, I0 the initial
fluorescence, Imax the fluorescence upon complete binding
with a cation. The initial (at t! 0) rapid rise of the internal
K+ concentration is followed by a slower phase, which is
described by first-order kinetics with respect to the K+-
gradient across the membrane:
dCin=dt ¼ kðCout  CinÞ
Integration gives the equation for the intravesicular K+
concentration:
Cin ¼ Cout  ðCout  C0inÞexpðktÞ;
where Cin
0 is the intravesicular K+ concentration after fast
initial influx (at t! 0). To determine the apparent rate
constant of K+/Me4N
+ exchange (k), fitting of the exper-
imental data was performed with the floated Cout value (Fig.
3B). For low concentrations of TRI, the Cout values were
lower than the external K+ concentration, showing that some
vesicles were not affected by TRI. At sufficiently high
concentrations of TRI, a complete equilibration of [K+]in
and [K+]out occurred, so that Cout =Cout
0 .
Fig. 4 shows the relationship between the cation diffu-
sion rate constant k and peptide concentration. The K+
Fig. 4. The K+/Me4N
+ exchange diffusion rate constant as a function of TRI
or ZER concentrations. The K+-uptake into PC vesicles was induced by
addition of peptides in the presence of a transmembrane gradient with
[K+]in < [K
+]out. CPC = 213 AM.
Fig. 3. (A) Time dependence of PBFI fluorescence emission upon additions
of different amounts of TRI to PC vesicles. The vesicles were loaded inside
with f 50 AM PBFI, 200 mM (CH3)4NCl, 10 mM TrisHCl (pH 7.4). The
bulk solution (the outside of the vesicles) contained 160 mM (CH3)4NCl, 40
mM KCl, 10 mM TrisHCl (pH 7.4). TRI was added to the indicated final
concentrations. GRA (2 AM) was used for complete equilibration of K+
across the membrane. CPC = 213 AM; kex = 340 nm, kem = 525 nm; 430 nm
cut-off filter. (B) The time dependence of intravesicular K+ concentration
upon addition to PC vesicles (at t = 0) of different amounts of TRI (final
concentrations are indicated near each curve). The experimental data shown
in panel A were transformed into intravesicular K+ concentration using the
preliminary determined dissociation constant of the indicator–K+ complex
(Kd = 7.8 mM). The dashed lines represent the best fit of the experimental
data with the relationship Cin =Cout (CoutCin0)exp( kt). All conditions
are the same as in Fig. 2.
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uptake mediated by ZER showed a much higher efficiency.
Compared to TRI, on the average, a 200-time smaller
concentration of ZER is required to get similar values of
k. Assuming that the rate constant is proportional to the
peptide concentration as: kf[peptide]N, a double logarith-
mic plot of k versus peptide concentration gives N=
3.4F 0.4 for TRI and N = 5.6F 1.6 for ZER. Thus, the
observed concentration dependence indicates some cooper-
ativity in both the TRI and ZER activities to enhance K+
transportation.
A comparison of K+- and Na+-influx in the presence of
peptides was made in parallel experiments with the same
vesicle preparation containing encapsulated PBFI with KCl
or NaCl as external electrolytes (Fig. 5A–D). The observed
differences in K+ and Na+ transport across a membrane
demonstrate that permeation of Me4N
+ ions is not rate-
limiting. Fig. 5A shows that in PC vesicles the TRI-induced
influx is more efficient for K+ than for Na+. The calculated
ratio of the K+/Na+ transport rates for 2 AM TRI shows an
about 1.6-time faster transport of K+ compared to Na+
(Table 2). For the acidic lipid PG membrane, even without
any peptide added, some uptake of K+, but not of Na+, was
observed (Fig. 5C). This finding is in line with the literature
data, which demonstrated that negatively charged lipids
facilitate cation diffusion across the membrane while pos-
itively charged membranes are highly cation impermeable
[26]. At the same concentration of TRI for PG vesicles (Fig.
5C) the difference between K+ and Na+ is higher (kK +/
kNa + = 2.9). However, with further increase of the TRI
concentration the discrimination in permeability between
K+ and Na+ is getting smaller (Table 2).
In the presence of low amounts of ZER (0.01 AM) the PG
membrane remains still more permeable to K+, but upon
Fig. 5. The time-course of K+- or Na+-uptake into pure PG vesicles (two curves at the bottom of panel C) and upon addition of TRI and ZER (at t = 0) to PC
vesicles (panels A, B) and to PG vesicles (panels C, D). The phospholipid vesicles contained inside 200 mM (CH3)4NCl, 10 mM TrisHCl (pH 7.4) and outside
200 mM KCl or NaCl, 10 mM TrisHCl (pH 7.4). CPC = 213 AM; CPG = 190 AM. Vesicle-encapsulated PBFI was used as a K+- and Na+-sensitive fluorescence
indicator.
Table 2
The ratio of rate constants of K+- and Na+-transport across the lipid
membrane in the presence of peptides
Peptide kK +/kNa +,
PC-membrane
kK +/kNa +,
PG-membrane
TRI (2 AM) 1.6 2.9
TRI (4 AM) 1.6 1.5
TRI (6 AM) 1.2 1.3
ZER (0.01 AM) 0.9 1.6
ZER (0.02 AM) 0.6 0.4
ZER (0.03 AM) 0.6 0.5
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further addition of ZER (0.02–0.03 AM) the Na+ influx
becomes about two times faster than that of K+ in both PC
and PG vesicles (Fig. 5B and D, Table 2).
3.3. Peptide-induced dissipation of the transmembrane
potential
To elucidate the influence of the transmembrane potential
Dw on the ability of TRI to permeate the lipid bilayer, Dw
was installed in LUVs with a K+ gradient across the
membrane by addition of the K+-ionophore VAL. Gener-
ation of Dw was followed with the potential-sensitive dyes
safranine T (Dw, cis-positive) [27,28] and oxonol VI (Dw,
cis-negative) [29,30]. When K+ is the only diffusing ion, the
magnitude of the installed Dw is given by the Nernst
equation:
Dw ¼ ðRT=FÞlnð½Kþin 	=½Kþout	Þ:
The sign of Dw refers to the extravesicular solution, which is
the cis-phase with respect to the added peptide. When VAL
was added to the vesicle dispersion with [Kin
+]>[Kout
+], the
fluorescence of safranine T (SAF) increased gradually
reaching a level that is stable for at least 60 min (Fig.
6A). The increase of OXO absorbance upon the addition of
VAL to vesicles with [Kin
+] < [Kout
+] was much faster (Fig.
6B). However, the response was less stable than for SAF
and about 10–20% of the initial response was lost during
the observation time even without the presence of peptide.
The observed spectral changes for both potential-sensitive
dyes correspond to those described by us previously [28].
The VAL-induced increase of fluorescence (or absorbance)
depends linearly on Dw in the range from + 40 to + 120 mV
(SAF) and from  20 to  120 mV (OXO) as it was
reported for small PC vesicles [28].
When TRI or ZER are added to LUVs with a pre-
installed Dw, dissipation of the potential is observed and
its kinetics appears to be dependent on the initial potential
and the peptide concentration (Fig. 6A and B). The
depolarisation of a membrane is due to the K+ efflux
and concomitant counterflow of Na+ leading to equilibra-
tion of external and internal concentrations of these ions.
The peptide ability to permeate a membrane was quantified
by: (1) the initial rate of potential dissipation; (2) the
amount of Dw dissipated during some time period,
expressed in percent with respect to the initial Dw value.
For both different peptides, Fig. 7A shows an increase of
the initial rate of potential dissipation upon installation of a
higher cis-positive membrane potential. For example, by an
increase of Dw from + 59 to + 118 mV, the rate increases
by a factor of 5 (for TRI) and 6 (for ZER). This effect
cannot be only due to different K+/Na+ gradients across a
membrane, since the difference [K+]in [K+]out (or [Na+]out
[Na+]in) is only 10% smaller for vesicles with Dw= + 59
mV compared to those having Dw= + 118 mV. The higher
efficiency of TRI (ZER) at elevated cis-positive potentials
is also demonstrated by the higher levels of vesicle depo-
larisation that is observed 10 min after peptide addition
Fig. 6. Dissipation of a transmembrane potential upon addition of TRI to polarised PC vesicles monitored with SAF and OXO as DW-sensitive fluorescence
absorbance indicators. Panel A (vesicles with cis-positive potentials) shows the time dependence of SAF fluorescence in the presence of a K+-transmembrane
gradient with [K+]in>[K
+]out. The PC vesicles contained: inside 200 mM KCl, outside variable KCl and NaCl concentrations (total concentration 200 mM) and
at both the in- and outside 10 mM TrisHCl (pH 7.4). VAL was added to develop a transmembrane potential (indicated near each curve) and subsequently TRI
(2.2 AM) was added. CPC = 111 AM, CVAL= 0.1 AM, CSAF = 1 AM; kex = 520 nm, kem = 580 nm. Panel B (vesicles with cis-negative potentials) shows the time
dependence of the OXO absorbance (k= 617 nm) in the presence of a K+-transmembrane gradient with [K+]in < [K
+]out. The PC vesicles contained inside 2 mM
KCl, 198 mM NaCl and variable concentrations of KCl and NaCl outside (total concentration 200 mM); both in- and outside concentrations of TrisHCl are 10
mM (pH 7.4). Subsequently, VAL and TRI were added. CVAL= 0.1 AM and CTRI = 3.7 AM. CPC = 172 AM, COXO = 1 AM.
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(Fig. 7B). However, for the negative outside potentials,
almost no changes were observed in both TRI- and ZER-
activity upon changing the initially installed potential (Fig.
8A and B).
For a given transmembrane potential, independent of
its sign, increasing the peptide concentration results in a
higher degree of membrane depolarisation (Fig. 9). At all
potentials studied, about 100-time lower concentrations of
Fig. 8. Effect of the cis-negative transmembrane potential Dw on the peptide-induced depolarisation of vesicles. (A) Dependence of the initial rate of potential
dissipation on the magnitude of the previously installed Dw. (B) The amount of dissipated potential as a function of initially installed potential. The rate was
monitored as usual (see text under Fig. 7) but using OXO as a Dw-sensitive probe. For both panels CPC = 172 AM, CTRI = 3.7 AM, CZER = 0.033 AM.
Fig. 7. Effect of the cis-positive transmembrane potential Dw on the peptide-induced depolarisation of vesicles. (A) Dependence of the initial rate of potential
dissipation on the magnitude of the initially installed Dw. The initial rate was measured at the linear part of the SAF fluorescence decrease caused by the
addition of the same concentration of peptide to vesicles with different magnitudes of initial Dw (see Fig. 6A for TRI). The fast small initial drop of Dw was not
taken into account and the rate was calculated for the next f 30-s interval. Similar experiments were performed with ZER. The decrease of fluorescence
intensity was recalculated into changes of Dw using the preliminary measured calibration curve (not shown). The dashed lines represent the best exponential fit
of the experimental data (see Discussion). (B) The amount of dissipated potential as a function of initially installed potential. The potential dissipated upon
peptide addition (10 min after addition) was expressed in percent with respect to the initial value of Dw. For both panels CPC = 111 AM, CTRI = 2.2 AM,
CZER = 0.025 AM.
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ZER were required to cause the same effect as that of
TRI.
4. Discussion
In the present study the ability of TRI and ZER to cause
permeation of monovalent cations (K+ and Na+) across the
lipid vesicular membrane was shown. The rate constants of
the peptaibol-mediated ion transport (Fig. 4) are a few
orders of magnitude larger than those for passive ion
diffusion through pure membranes. (For a permeability
coefficient of monovalent cations in pure membranes being
in the range P= 10 14–10 12 cm/s [31], the calculated rate
constant for vesicles with a radius of 450 A˚ is within the
6.7
 10 9–6.7
 10 7 s 1 range).
It was of interest to estimate the number of peptaibol
molecules bound per one vesicle capable to cause K+
leakage. Assuming that the full bilayer thickness (choline-
to-choline) for egg PC is ~55 A˚ and the area occupied by
one PC molecule in the bilayer is f 70 A˚2, for a vesicle
with the outer diameter of 900 A˚ the calculated number of
PC molecules per one vesicle is f 64,400. Consequently,
depending on the peptaibol concentration, one vesicle con-
tains three to nine molecules of ZER. The observed power
dependence of the ion diffusion rate on ZER concentrations
(kf [Peptide]N), with N in the range 4–7 (Fig. 4), might be
an indication of the size of ZER aggregates participating in
ion transportation over the examined concentration range.
This is in agreement with the molecularity of ZER channels
determined from conductivity measurements on planar lipid
membranes with 4–16 ZER monomers per channel [9].
Thus, only one or two channels per vesicle are enough to
cause complete equilibration of K+ concentration across a
membrane.
A parallel study of both TRI and ZER showed a lower
efficiency of the undecapeptide compared to the hexadeca-
peptide. To get similar effects on the membrane about a 200-
fold higher concentrations of TRI were required (Fig. 4).
Much larger amounts of TRI (300–2300 TRI molecules per
vesicle) necessary for ion transportation make the channel
mechanism for this short peptaibol rather unlikely. Though
the concentration of membrane-bound TRI is very high, the
cooperativity of TRI action is less pronounced (N = 3–4),
but still showing that some peptide aggregation is involved
in ion permeation (see below).
The discrimination in the permeability between K+ and
Na+ observed in the presence of TRI and ZER is different
(Fig. 5, Table 2). Upon addition of TRI a faster permeation
was found for K+ than for Na+, especially noticeable for low
TRI concentrations in the PG membrane. Such behaviour of
K+ and Na+ corresponds to the relative mobility’s of these
ions in pure lipid bilayer. The discrimination in K+/Na+
permeability by pure lipid membrane is significant for
membranes composed of acidic [32] and very unsaturated
lipids [33]. The reported ratios of K+ to Na+ diffusion rates
are 2.4 (PC + 15% phosphatidic acid), 5.4 (PG) and 9.0 (PS)
[32].
The preference of K+ over Na+ diffusion through a pure
membrane can be understood, considering the fact that the
most likely mechanism for ion transport is permeation
through water-filled pores arising from packing defects in
the bilayer structure [34]. The probability for an ion to enter
such a ‘‘statistical pore’’ is decreased with increasing the
size of permeating hydrated ion, thus explaining the
observed order: K+ (r+K(aq) = 1.8 A˚)>Na
+ (r+Na(aq) = 3.3 A˚).
Thus, the preferential permeation of K+ over Na+ at low TRI
concentrations follows the tendency found for passive
diffusion of these ions in pure lipid bilayers. Such finding
allows us to suggest that in the presence of a low TRI
concentration the principle mechanism of ion permeation is
not changed much compared to the pure membrane. How-
ever, at higher TRI concentrations, the discrimination
between the K+/Na+ fluxes becomes smaller (Table 2) and
some additional mechanism of ion transport might be
operative (see below).
The K+/Na+ membrane permeation found in the presence
of ZER (Fig. 5B and D, Table 2) is reversed (Na+>K+)
compared to that mediated by TRI. The observed faster
transportation of Na+ via ZER channels is also different
from the permeation sequence found from conductivity
measurements for ALA channels (K+>Na+>Li+) [35,36].
The observed difference in Na+ and K+ permeation caused
by ZER is weak (rate ratio about 2:1), especially when
compared with the permeability ratio PNa +/PK + (f 14)
observed for biological Na+ channels [37]. The selectivity
sequence Na+>K+ for ion permeation through a channel is
Fig. 9. The amount of dissipated potential as a function of peptide
concentration at a constant Dw =+ 78 mV. The potential dissipated upon
addition to polarised PC vesicles (10 min after addition) was expressed in
percent with respect to the initial value of Dw. CPC = 111 AM.
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often the result of a stronger interaction of the ion with the
binding sites of the channel compared to ion–water inter-
actions [13,20]. In this respect, it is of interest to compare
two characteristic motifs of the respective primary structures
of ZER and ALA, i.e. Aib7-X-X-Hyp10 and Gly11-X-X-
Pro14 [38,39]. The molecular structure of ZER shows that,
independent of its crystalline [11], solution [12] or micellar
bound state [13], the carbonyl of Aib7 is at the centre of the
concave face of a kinked helix. From the crystal packing
[11] and the aggregate structure found in frozen solution
[40], it is known that the amphipathic helices are associated
to a ‘hydrophilic channel like’ bundle of antiparallel ori-
ented peptides. In the middle, the channel is closed by two
inter-molecular hydrogen bonds between backbone carbon-
yls (Aib7 and Thr6 in the respective molecules A and B) and
amino acid side chains (the HO-group of Hyp10 in molecule
B and the amide group of Gln11 in A) [11]. After cleavage of
the inter-molecular (Aib7)CMO. . .HO(Hyp10) hydrogen
bond, specific binding of the smaller nonhydrated Na+ ion
(r+Na = 0.95 A˚ vs. rK
+ = 1.33 A˚) to the intra-molecular
(Aib7)CMO. . .N(Hyp10) site can occur which might be a
plausible explanation for the observed selectivity of ion
conduction. The different ion selectivity observed for ALA
might be due to the fact that the Gly11-X-X-Pro14 motif of
ALA is located just outside the centre of the kinked helical
molecule at the wider part of the hydrophilic channel. Thus,
for ALA the cation moves through the channel in the
hydrated form with the rate proportional to the ion diffusion
coefficient in water which depends on its size (rK(aq)
+ <
rNa(aq)
+).
Since most of the studies on peptaibols membrane
activity were performed with planar lipid bilayers, ion
conduction was observed under potential-controlled condi-
tions. Contrarily, in vesicular model systems potential-inde-
pendent ion conduction could be observed for both ZER
[28] and ALA [1,6,41,42]. In the present study it was shown
that both ZER and TRI could also cause ion permeation
through a vesicular membrane in the absence of any trans-
membrane potential. Thus, the transmembrane voltage is not
an obligatory factor for ion transport induced by both
studied peptaibols, though installation of a potential (of a
proper polarity) indeed increases the peptaibols activity. The
potential-independent membrane activity of long-chain pep-
taibols can be well explained by the existence of an
equilibrium between the surface bound and transmembrane
orientations of the peptide [43–48]. The amount of the
transmembrane state depends on a number of factors includ-
ing the hydrophobic length of the peptide, the lipid compo-
sition, L:P ratio, etc. The 16-residue-long ZER showed a
distribution in the orientation when it is bound to DOPC (di-
C18:1) or 1,2-dicapryl-sn-glycero-3-phosphocholine (di-
C10:0) bilayers [47], so that the fraction of transmembrane
orientated peptide can participate in channel formation.
Contrarily, a transmembrane state for the 11-residue TRI
is less likely [45] and even then the helix length (15–16 A˚)
is not enough to span the bilayer. Recent EPR studies
revealed that the TRI helix is bound parallel to the mem-
brane within the lipid head-group region [17]. This mode of
binding, together with the insertion of TRI octanoyl tail into
the core of the membrane, would perturb the local packing
of the hydrophobic membrane pocket, thus increasing the
amount of ‘‘statistical pores’’ mentioned above. This is
similar to the ‘‘in-plane diffusion’’ model suggested in Refs.
[46,49] to explain the membrane activity of different pep-
tides. The importance of aliphatic chain insertion for TRI
membrane activity was shown by the study of synthetic
[Leu11OMe]trichogin GA IV analogues with variable acyl
chain lengths (C2–C18) [16]. The C8–10 derivatives were
found the most efficient, while C2 analogue was completely
inactive. (However, upon further increasing the chain length
of the aliphatic side chain to C16–18 atoms, the membrane
activity is decreased).
On the other hand, Fig. 4 shows that the ion diffusion
rate of TRI is dependent on the on the 3rd–4th power of the
TRI concentration, which may indicate that aggregates
(trimers and/or tetramers) of TRI are involved in ion
permeation. Recently, the aggregation properties of TRI
molecules have been studied by means of PELDOR- and
CW-EPR spectroscopy as well. In hydrophobic solvents
(chloroform and chloroform–toluene mixtures) aggregates
containing four peptide molecules are formed, which dis-
sociate upon addition of polar solvents (alcohols) [50,51].
Based on distance measurements between spin labels,
incorporated at well-defined positions of the TRI molecules,
a ‘vesicular’ model was proposed for the aggregate com-
posed of four TRI molecules oriented in an antiparallel
fashion (the diagonal positioned helices are parallel ori-
ented) [50,51]. The side chains of the apolar amino acid side
chains are facing outwards, whereas the polar groups are
facing towards a cavity that is closed by both the N-terminal
octanoyl groups and the bulky side chains of the C-terminal
leucine residues. It might be speculated that at higher
concentrations of TRI the solvated ions might be entrapped
into this polar pocket of the tetramer formed by association
of monomers that are bound at one side of the membrane.
After diffusion across the bilayer, the aggregate might
dissociate to peptide monomers upon reaching the polar
lipid head group region of the other side of the membrane.
The length of the octanoyl side chain is supposed to be
critical in the formation of opening and closing of the
vesicular system, which is in agreement with the observed
lack of ion conduction for both short and long aliphatic side
chain analogues. It should be noticed that the microscopic
peptide concentrations used in our experiments, i.e. the
concentration of TRI in the membrane phase of the phos-
pholipid vesicles, are in the range of 5–30 mM. This is
similar to the concentrations when the equilibrium between
monomers and tetramer in hydrophobic solvents was
observed [50–52].
The behaviour of TRI and ZER with respect to the
transmembrane potential was found to be the same: in
LUV both peptides were activated by imposing of cis-
T.N. Kropacheva, J. Raap / Biochimica et Biophysica Acta 1567 (2002) 193–203 201
positive, but not of cis-negative potentials (Figs. 7 and 8).
Similar asymmetric current–voltage curves were observed
for both Gln18 and Glu18 analogues of ALA in planar lipid
bilayers [2,53,54]. The dissipation of the transmembrane
potential, caused by peptide addition (Fig. 6), depends on
the peptide-mediated K+ efflux in exchange for the influx of
extravesicular Na+. Thus, the data presented in Fig. 7A can
be interpreted as a voltage dependence of the apparent K+/
Na+ exchange rate [55]. Similar to the voltage dependence
of macroscopic conductance (Gf exp(V/Ve), characterised
by the Ve—voltage required to produce an e-fold increase in
conductance [4,6], the increase of ion transport rate (Fig.
7A) may be approximated with an exponential function. The
found values of Ve are practically the same for both
peptaibols (Ve = 34 mV for ZER and Ve = 38 mV for TRI).
Compared to the voltage dependence of conductance
observed for ZER in planar bilayers with Ve = 4.5 mV [9],
in vesicular system the voltage activation of ZER is less
steep. This resembles the situation with ALA, which is
characterised with a Ve value of f 20 mVand of 4–9 mV in
vesicles and planar bilayers, respectively [2,6,36,53,54].
The observed potential-dependent behaviour of the pep-
taibols studied can be explained in terms of a voltage-
induced insertion/reorientation mechanism (reviewed in
Ref. [6]). The peptaibol helix dipole (equivalent with a
partial positive and a negative charge at the N- and C-
terminus, respectively) causes a reorientation of the peptai-
bol molecule in the external electric field, so that the fraction
of peptaibol oriented perpendicular to the membrane
increases. Activation of ZER at cis-positive potentials
observed in this study as well as before [9,28] shows that
insertion of the N-terminus into the bilayer interior is more
favourable for channel formation. This binding mode
closely resembles that of ALA in which the N-terminus is
extended into the central bilayer region even without any
transmembrane potential [56–59]. For ZER the higher
selectivity for penetration of the N-terminal end into the
bilayer is even more likely due to the higher proportion of
polar residues at the opposite C-terminal part of the mole-
cule. The deeper insertion of N-terminus compared to the
other part of the molecule was also found for ZER bound to
a micelle [13]. Thus, the mechanism of voltage activation of
both ZER and ALA is better characterised in terms of a pre-
orientation/insertion [13] rather than insertion/reorientation
model.
In case of TRI, the selective insertion of the N-terminus
through the bilayer followed by aggregation and diffusion
towards the negatively charged inner surface of the vesicle
is initiated by a preferable stabilisation of the octanoyl tail,
which is deeply buried into the hydrophobic membrane
pocket.
In summary, the present study clearly establishes that the
short-chain peptaibol trichogin GA IV can enhance metal
ion permeation across phospholipid vesicular membrane.
The low membrane activity and the relatively small number
of trichogin molecules that are involved in ion translocation
seem to exclude the possibility of ion channel formation by
this short-chain lipopeptaibol.
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